126 related articles for article (PubMed ID: 38756782)
1. Case report: Decreased hemoglobin and multiple organ failure caused by ceftizoxime-induced immune hemolytic anemia in a Chinese patient with malignant rectal cancer.
Lou C; Liu M; Ma T; Yang L; Long D; Li J; Lei H; Xiang D; Wang X; Li L; Cai X
Front Immunol; 2024; 15():1390082. PubMed ID: 38756782
[TBL] [Abstract][Full Text] [Related]
2. A case of immune hemolytic anemia induced by ceftizoxime and cefobactam (sulbactam/cefoperazone).
Baek EJ; Lee S; Kim S; Choi HK; Kim HO
Korean J Lab Med; 2009 Dec; 29(6):578-84. PubMed ID: 20046091
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced immune hemolytic anemia.
Garratty G
Hematology Am Soc Hematol Educ Program; 2009; ():73-9. PubMed ID: 20008184
[TBL] [Abstract][Full Text] [Related]
4. Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia.
Arndt PA; Leger RM; Garratty G
Transfusion; 2012 Mar; 52(3):602-12. PubMed ID: 21880048
[TBL] [Abstract][Full Text] [Related]
5. Immune hemolytic anemia with drug-induced antibodies to carboplatin and vincristine in a pediatric patient with an optic pathway glioma.
Betensky M; Witmer C; Fisher MJ; Nance S; Weiss MJ; Sesok-Pizzini DA
Transfusion; 2014 Nov; 54(11):2901-5. PubMed ID: 24860959
[TBL] [Abstract][Full Text] [Related]
6. Marked reduction in haemoglobin levels secondary to ceftizoxime-induced immune haemolytic anaemia in diabetic patients.
Wu S; Jing L; Feng Y; Chen L
J Clin Pharm Ther; 2020 Aug; 45(4):812-814. PubMed ID: 32319116
[TBL] [Abstract][Full Text] [Related]
7. First two cases of immune hemolytic anemia associated with ceftizoxime.
Shammo JM; Calhoun B; Mauer AM; Hoffman PC; Baron JM; Baron BW
Transfusion; 1999 Aug; 39(8):838-44. PubMed ID: 10504119
[TBL] [Abstract][Full Text] [Related]
8. Immune hemolytic anemia caused by drugs.
Garratty G
Expert Opin Drug Saf; 2012 Jul; 11(4):635-42. PubMed ID: 22502777
[TBL] [Abstract][Full Text] [Related]
9. Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature.
Leicht HB; Weinig E; Mayer B; Viebahn J; Geier A; Rau M
BMC Pharmacol Toxicol; 2018 Oct; 19(1):67. PubMed ID: 30359322
[TBL] [Abstract][Full Text] [Related]
10. Piperacillin-tazobactam induced immune hemolytic anemia led to increased renal impairment and eventual death from multiple organ failure in a patient with hypertensive nephropathy: case report and literature review.
Wu Y; Wu Y; Guo G; Zeng J; Liu Y; Wu Y
BMC Nephrol; 2023 Jun; 24(1):173. PubMed ID: 37316798
[TBL] [Abstract][Full Text] [Related]
11. Severe drug-induced immune hemolytic anemia due to cefmetazole: A case report.
Fukuda M; Nabeta M; Oya S; Takasu O
Int J Clin Pharmacol Ther; 2022 Jan; 60(1):52-56. PubMed ID: 34672255
[TBL] [Abstract][Full Text] [Related]
12. Ceftriaxone-Induced Hemolytic Anemia: A Rare Case Report.
Kumar S; Bansal R; Bansal P; Dhamija RK; Neurology D
Perm J; 2020; 24():. PubMed ID: 31905339
[TBL] [Abstract][Full Text] [Related]
13. Serologic characteristics of oxaliplatin antibodies in 15 patients with drug-induced immune hemolytic anemia.
Nguyen TN; Maenulein E; Fihman V; Vinatier I; Moh Klaren J
Transfusion; 2021 May; 61(5):1609-1616. PubMed ID: 33686704
[TBL] [Abstract][Full Text] [Related]
14. Ceftizoxime-induced hemolysis secondary to combined drug adsorption and immune-complex mechanisms.
Calhoun BW; Junsanto T; Donoghue MT; Naureckas E; Baron JM; Baron BW
Transfusion; 2001 Jul; 41(7):893-7. PubMed ID: 11452157
[TBL] [Abstract][Full Text] [Related]
15. Drug-induced immune hemolytic anemia: the last 30 years of changes.
Arndt PA
Immunohematology; 2014; 30(2):44-54. PubMed ID: 25247622
[TBL] [Abstract][Full Text] [Related]
16. The changing spectrum of drug-induced immune hemolytic anemia.
Arndt PA; Garratty G
Semin Hematol; 2005 Jul; 42(3):137-44. PubMed ID: 16041663
[TBL] [Abstract][Full Text] [Related]
17. Case report: First case of pemetrexed plus cisplatin-induced immune hemolytic anemia in a patient with lung adenocarcinoma.
Lu H; Wang N; Wang P; Zhang H; Zhao R; Liu H; He X; Liu Z; Chang Y; Cao Y; Wang S
Front Med (Lausanne); 2022; 9():917485. PubMed ID: 36091696
[TBL] [Abstract][Full Text] [Related]
18. Severe drug-induced immune hemolysis due to ceftriaxone.
Dara RC; Sharma R; Bhardwaj H
Asian J Transfus Sci; 2020; 14(2):187-191. PubMed ID: 33767548
[TBL] [Abstract][Full Text] [Related]
19. Ceftizoxime-induced hemolysis due to immune complexes: case report and determination of the epitope responsible for immune complex-mediated hemolysis.
Endoh T; Yagihashi A; Sasaki M; Watanabe N
Transfusion; 1999 Mar; 39(3):306-9. PubMed ID: 10204595
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune hemolytic anemia associated with trimethoprim-sulfamethoxazole use.
Frieder J; Mouabbi JA; Zein R; Hadid T
Am J Health Syst Pharm; 2017 Jun; 74(12):894-897. PubMed ID: 28596226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
